JOHN MARSELLA: Open Payments
NPI 1326027236 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 58 payments from 9 companies in 2025. Trend: 2023 $220 · 2024 $1,851 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $299 |
| Forte Bio-Pharma LLC | 20 | $223 |
| Boston Scientific Corporation | 6 | $211 |
| MML US, Inc. | 5 | $166 |
| Collegium Pharmaceutical, Inc. | 5 | $89 |
| IBSA Pharma Inc. | 3 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| BIOTRONIK NRO, Inc. | 1 | $17 |
Products named: PROLATE, PROCLAIM, ReActiv8, WaveWriter Alpha Prime 16, ETERNA, Belbuca, General - Pain Management, Tirosint.
Industry payments across AL — which companies pay providers there.
